CALGARY, ALBERTA--(Marketwire - Dec. 11, 2007) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) is pleased to announce that Drs. Trina Johnson, Wee Yong and Samuel Weiss will be presenting preliminary results from a study of the pro-inflammatory effects of prolactin in a mouse model of Multiple Sclerosis (MS) at the Canadian endMS Research Conference held in Banff, Alberta, from December 10th through the 13th. The work of Drs. Johnson, Yong and Weiss explores prolactin's role as a therapy in acute and chronic central nervous system (CNS) disease settings.
